BTIG Maintains Buy Rating on Verastem With $24 Price Target
BTIG maintained its Buy rating and $24.00 price target on Verastem. The target implies 211.3% upside from the October 14 close of $7.71.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.